Strategies of emerging countries to expand the operations to the global market of biopharmaceuticals

Ria Christine Siagian, Novilia Bachtiar, Prastuti Soewondo

Research output: Contribution to journalReview articlepeer-review


The past decade has seen an increasing number in production of newly-developed biopharmaceuticals, biosimilars and biobetters that can help contribute to improved global health. Global market growth in this industry was reported to increase and approach more than US$200 billion. As the industry matures, the growth is significantly higher in emerging markets than in developed countries. This shows a shift of biopharmaceuticals production outside of developed countries, thereby sending signals to emerging countries the opportunity to become global leaders in new industries. This literature review seeks to identify the commercial levers in biopharmaceutical development in emerging countries. The study found that biopharmaceuticals industry was promising for emerging countries to compete in global market if it were supported by strong government involvement. This involvement revealed key strategies to improve poor pipeline productivity shaped by political, economic, technological and market factors.

Original languageEnglish
Pages (from-to)7-12
Number of pages6
JournalIndian Drugs
Issue number6
Publication statusPublished - Jun 2021


  • Biopharmaceuticals
  • Emerging countries
  • Governance
  • Innovation policy
  • Pharmaceutical industry


Dive into the research topics of 'Strategies of emerging countries to expand the operations to the global market of biopharmaceuticals'. Together they form a unique fingerprint.

Cite this